Valley National Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History

Valley National Advisers’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-422	Closed	-$2K	–	907
2021 Q3	$2K	Hold	422	–	–	﹤0.01%	748
2021 Q2	$2K	Hold	422	–	–	﹤0.01%	766
2021 Q1	$3K	Hold	422	–	–	﹤0.01%	677
2020 Q4	$2K	Hold	422	–	–	﹤0.01%	676
2020 Q3	$2K	Hold	422	–	–	﹤0.01%	639
2020 Q2	$2K	Hold	422	–	–	﹤0.01%	637
2020 Q1	$1K	Buy	+422	New	+$1.79K	﹤0.01%	670
2019 Q4	–	Sell	-422	Closed	-$1K	–	747
2019 Q3	$1K	Hold	422	–	–	﹤0.01%	702
2019 Q2	$3K	Buy	+422	New	+$4.32K	﹤0.01%	591

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return